Sanofi Stumbles as Key Medicines' Sales Spark Growth Concerns

Sanofi Stumbles as Key Medicines' Sales Spark Growth Concerns

Source: 
Bloomberg
News Tags: 
snippet: 

A handful of Sanofi’s top drugs stumbled in the first quarter, sparking concern about growth as the French drugmaker attempts to become a leader in blood disorders via $16 billion in acquisitions.